While there is hope that the worst of the pandemic is behind us, hundreds of thousands of new cases of COVID-19 are still reported daily around the globe. That is why it's so important to continue to advance not only prevention, but also treatment of COVID-19. These clinical trials are evaluating whether an oral study drug reduces the duration and/or severity of illness among people with COVID-19 or prevents the onset of COVID-19 symptoms in household members.
COVID-19 — Recently Diagnosed Or Symptomatic Children And Teens At Increased Risk Of Severe Illness From COVID-19
For children and teens who have COVID-19 symptoms or have recently tested positive for COVID-19, and have health conditions that put them at risk for severe illness. Now enrolling.
COVID-19 — RECENTLY DIAGNOSED, SYMPTOMATIC PEOPLE WHO ARE IMMUNOCOMPROMISED
For people 12 years of age or older who recently tested positive for COVID-19, currently have at least 1 sign/symptom, and have health conditions that put them at risk for severe illness. Click to learn more, or call us at 800-887-7002. Now enrolling.
PREGNANT WOMEN WITH RECENTLY DIAGNOSED, SYMPTOMATIC COVID-19
A COVID-19 clinical research study is underway to compare the pharmacokinetics (how a drug is absorbed, distributed, and processed in the body) and tolerability of PAXLOVID™ in pregnant versus non-pregnant women ages 18 to 50 with mild-to-moderate symptomatic COVID-19. Now enrolling.
COVID-19 — RECENTLY DIAGNOSED PATIENTS AT INCREASED RISK OF WORSENING SYMPTOMS
For those 18 years of age and older who have COVID-19 symptoms, as well as health conditions that put them at high risk for severe illness. No longer enrolling.
COVID-19 — FOR HOUSEHOLD MEMBERS OF THOSE RECENTLY DIAGNOSED
For adults living in the same home as individuals with diagnosed, symptomatic COVID-19. No longer enrolling.
COVID-19 — RECENTLY DIAGNOSED PATIENTS
For those 18 years of age and older who have COVID-19 symptoms and have tested positive for COVID-19 within the last 5 days, but do not have any health conditions putting them at risk for severe illness, or have these conditions but are fully vaccinated. No Longer Enrolling.